હોમ › ફેફસાનું કેન્સર › ઇલિનોઇસ › Chicago
Chicago, IL માં ફેફસાનું કેન્સર ક્લિનિકલ ટ્રાયલ્સ
Chicago (લગભગ 30 માઇલની અંદર) ની સાઇટ્સ પર ફેફસાનું કેન્સર માટે 41 અભ્યાસો ભાગીદારો શોધી રહ્યા છે. કોઈ અભ્યાસ ખોલો અને જુઓ કે કોઈ જોડાઈ શકે છે અને અભ્યાસ ટીમ સાથે સંપર્ક કેવી રીતે કરવો.
અધિકૃત અભ્યાસ ટેક્સ્ટ (અંગ્રેજી)
અહીં અભ્યાસ માટે ભરતી કરી રહ્યા છો? આ પેજની ટોચ પર તેને ફીચર કરો — 30 દિવસ માટે $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ભરતી ચાલુ છેફેઝ 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- અને 1 વધુ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- અને 1 વધુ
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
ભરતી ચાલુ છેફેઝ 1/2
- University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ભરતી ચાલુ છેફેઝ 2
- University of Illinois Cancer Center, Chicago
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ભરતી ચાલુ છેફેઝ 3
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Northwestern University, Chicago
- University of Illinois, Chicago
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ભરતી ચાલુ છેફેઝ 3
- Northwestern University, Chicago
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ભરતી ચાલુ છેફેઝ 3
- University of Illinois Cancer Center, Chicago
- Center for Care and Discovery, Chicago
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
- Illinois Cancer Specialists, Chicago
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
ભરતી ચાલુ છેફેઝ 3
- University of Illinois Chicago, Chicago
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
ભરતી ચાલુ છેફેઝ 2
- Rush University Medical Center, Chicago
- University of Illinois Chicago, Chicago
A Registry for People With Lung Cancer
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Rush University Medical Center (Data collection only), Chicago
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Research Site, Chicago
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
ભરતી ચાલુ છેફેઝ 2/3
- Rush University Medical Center, Chicago
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ભરતી ચાલુ છેફેઝ 1
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
ભરતી ચાલુ છેફેઝ 3
- University of Illinois Hospital and Health Sciences Systems, Chicago
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ભરતી ચાલુ છેફેઝ 3
- Northwestern University, Chicago
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
ભરતી ચાલુ છેફેઝ 1
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- o University of Chicago Medicine Comprehensive Cancer Center, Chicago
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
ભરતી ચાલુ છે
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
ભરતી ચાલુ છેફેઝ 1/2
- University of Chicago, Chicago
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
ભરતી ચાલુ છેફેઝ 1/2
- Northwestern Memorial Hospital, Chicago
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2/3
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ભરતી ચાલુ છેફેઝ 1/2
- Northwestern Memorial Hospital, Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- University of Illinois Cancer Center, Chicago
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- University of Illinois at Chicago, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
ભરતી ચાલુ છેફેઝ 2
- University of Chicago Medicine, Chicago
Lung Cancer Screening in High-risk Black Individuals
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- University of Chicago, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ભરતી ચાલુ છેફેઝ 1
- The University of Chicago Comprehensive Cancer Center, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Advocate Illinois Masonic Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Massive Bio SYNERGY-AI site, Chicago
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- University of Chicago, Chicago
Olaparib in Patients With HRD Malignant Mesothelioma
ભરતી ચાલુ છેફેઝ 2
- University of Chicago Medical Center, Chicago
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Northwestern University, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
ભરતી ચાલુ છેફેઝ 2
- Northwestern University, Chicago
અન્ય શહેરોમાં ફેફસાનું કેન્સર ટ્રાયલ્સ
- Houston, TX78 અભ્યાસો
- Boston, MA62 અભ્યાસો
- New York City, NY60 અભ્યાસો
- Los Angeles, CA45 અભ્યાસો
- Arlington, VA41 અભ્યાસો
- Washington, DC41 અભ્યાસો
- Nashville, TN40 અભ્યાસો
- Baltimore, MD40 અભ્યાસો
- St. Louis, MO39 અભ્યાસો
- Columbus, OH37 અભ્યાસો
- Philadelphia, PA36 અભ્યાસો
- Seattle, WA33 અભ્યાસો
Chicago માં અન્ય અભ્યાસો
- નોન-સ્મોલ સેલ લંગ કેન્સર61 અભ્યાસો
- સ્તન કેન્સર58 અભ્યાસો
- કેન્સર (બધા પ્રકાર)51 અભ્યાસો
- મેટાસ્ટેટિક કેન્સર45 અભ્યાસો
- પ્રોસ્ટેટ કેન્સર45 અભ્યાસો
- સ્થૂળતા41 અભ્યાસો
- ઓવેરિયન કેન્સર36 અભ્યાસો
- સ્ટ્રોક34 અભ્યાસો
- કોલોરેક્ટલ કેન્સર33 અભ્યાસો
- હૃદય અપૂરતાપણું31 અભ્યાસો
- ઓવરવેઇટ28 અભ્યાસો
- માથું અને ગળાનો સ્ક્વેમસ સેલ કાર્સિનોમા26 અભ્યાસો
ClinicalTrials.gov પરથી, તારીખ 5 ઑક્ટો, 2026 ના ડેટા સાથે. દરેક અભ્યાસની પોતાની પાત્રતા શરતો હોય છે; અભ્યાસ ટીમ નક્કી કરે છે કે કોઈ જોડાઈ શકે છે કે નહીં.